Abbott Faces Trial Over Claims That Preterm Infant Formula Caused Dangerous Disease Ensuring Safety in Neonatal Care
Abbott Laboratories, the maker of Similac baby formula, is set to face a trial on Monday regarding allegations that its preterm infant formula used in neonatal intensive care units (NICUs) has led to the development of...
Jul 10, 2024
• Major Pharmaceutical Preparations Industry
Stocks on the Move
Abbott Abbott Vietnam Beryl P Taiwan December Abbo
